As health care costs continue to rise, governments and private payers are being forced to make difficult coverage decisions about new health care treatments. Cost-effectiveness (CE) analysis is the main method used to prioritize this spending. The self-evident efficiency rationale for CE is that resources should be spent where they have the highest health impact. This has led to perhaps the largest field in health economics which attempts to provide better estimates of value through CE analysis. However, the costs invariably used in CE analysis are prices set by producers rather than resources used to produce treatments. Therefore, observed CE levels are endogenous because the pricing of new technologies is chosen to maximize profits. This is important because optimal prices, and hence observed CE levels, are affected by demand factors such as patient/doctor demand and payer adoption policies. This implies that traditional measures of “costs” reflect these demand-determined mark-ups rather than resource costs and moreover, CE-based reimbursement policies affect the endogenous CE levels payers observe. Reimbursement based on endogenous CE may therefore bear little relationship with efficient use of scarce medical resources. Using data from technology appraisals by the National Institute for Health and Clinical Excellence (NICE), we test for conditions under which adoption based on standard CE analysis may lead to adoption of more inefficient technologies in terms of resource use.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Publisher Info
Paper provided by National Bureau of Economic Research, Inc in its series NBER Working Papers with number
15032.
Length: Date of creation: Jun 2009 Date of revision: Handle: RePEc:nbr:nberwo:15032
Note: AG HC HE Contact details of provider: Postal: National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A. Phone: 617-868-3900 Email: Web page: http://www.nber.org More information through EDIRC
For technical questions regarding this item, or to correct its listing, contact: ().
Related research
Keywords:
Find related papers by JEL classification: I0 - Health, Education, and Welfare - - General I1 - Health, Education, and Welfare - - Health I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
This paper has been announced in the following NEP Reports:
References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.: